Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Sven Arne Silfverdal, Vanessa Coremans, Nancy François, Dorota Borys & Jan Cleerbout. (2017) Safety profile of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV). Expert Review of Vaccines 16:2, pages 109-121.
Read now
Read now
Articles from other publishers (3)
Amna Siddiqui, Alishba Adnan, Munib Abbas, Shafaq Taseen, Sidhant Ochani & Mohammad Yasir Essar. (2022)
Revival of the heterologous prime‐boost technique in
COVID
‐19: An outlook from the history of outbreaks
. Health Science Reports 5:2.
Crossref
Crossref
Young June Choe, Daniel B. Blatt, Hoan Jong Lee & Eun Hwa Choi. (2020) Associations between geographic region and immune response variations to pneumococcal conjugate vaccines in clinical trials: A systematic review and meta-analysis. International Journal of Infectious Diseases 92, pages 261-268.
Crossref
Crossref
Melinda M. Pettigrew, Mark R. Alderson, Lauren O. Bakaletz, Stephen J. Barenkamp, Anders P. Hakansson, Kevin M. Mason, Johanna Nokso‐Koivisto, Janak Patel, Stephen I. Pelton & Timothy F. Murphy. (2017) Panel 6: Vaccines. Otolaryngology–Head and Neck Surgery 156:S4.
Crossref
Crossref